4//SEC Filing
Valence Investments SPV IV LLC 4
Accession 0001209191-23-027196
CIK 0001534133other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:53 PM ET
Size
17.5 KB
Accession
0001209191-23-027196
Insider Transaction Report
Form 4
Valence Investments SPV IV LLC
10% Owner
Transactions
- Award
Common Stock
2023-03-20+356,989→ 356,989 total - Award
Common Stock
2023-03-20+66,228→ 66,228 total(indirect: By LLC) - Award
Common Stock
2023-03-20+316,109→ 316,109 total(indirect: By LLC) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-06-25→ Common Stock (9,935 underlying) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-02-22→ Common Stock (9,935 underlying)
Valence Investments SPV V, LLC
10% Owner
Transactions
- Award
Common Stock
2023-03-20+356,989→ 356,989 total - Award
Common Stock
2023-03-20+66,228→ 66,228 total(indirect: By LLC) - Award
Common Stock
2023-03-20+316,109→ 316,109 total(indirect: By LLC) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-02-22→ Common Stock (9,935 underlying) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-06-25→ Common Stock (9,935 underlying)
Valence Investments SPV VI, LLC
10% Owner
Transactions
- Award
Common Stock
2023-03-20+356,989→ 356,989 total - Award
Common Stock
2023-03-20+66,228→ 66,228 total(indirect: By LLC) - Award
Common Stock
2023-03-20+316,109→ 316,109 total(indirect: By LLC) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-02-22→ Common Stock (9,935 underlying) - Award
Warrant
2023-03-20+9,935→ 9,935 total(indirect: By LLC)Exercise: $27.94Exp: 2026-06-25→ Common Stock (9,935 underlying)
Footnotes (5)
- [F1]Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
- [F2]Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
- [F3]Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
- [F4]Immediately exercisable.
- [F5]Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement.
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001812080
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 8:53 PM ET
- Size
- 17.5 KB